Investigator-Initiated Studies

We’re committed to supporting investigator-initiated research that promotes the advancement of medical and scientific knowledge involving AbbVie’s products and therapeutic areas of interest.

Advancing science through investigator-led research

The research from Investigator-Initiated Studies may expand our understanding of our products and their potential applications. Plus, it may improve patient care and spark new ideas for further disease-related research.

The AbbVie IIS Program provides an opportunity to academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support.

Visit the IIS Submission Portal to learn more or to apply.

How to apply

If you’re an investigator, you can initiate the application process by submitting a brief summary of the proposed research to AbbVie through our IIS Portal. IIS applications are accepted on a rolling submission basis.

For assistance on how to submit an IIS application as a non-AbbVie submitter to the SPIRIT portal, please refer to the training guide here.  

After you apply

Following the review of the initial submission, you may be asked to submit a full protocol and final study budget for further evaluation. We hold protocol review meetings monthly. Submission of a proposal does not imply or guarantee approval. The committee evaluates proposals according to their scientific merit, alignment with our areas of research interest and available funding. Financial and/or product support is contingent upon full execution of the research agreement by both parties.

Therapeutic areas of interest

To learn more about our 2020 strategic IIS priorities, download the document here.